Stephen Kamin

Statistics

Publications

Citations

706

H-Index

Active since

1991

Affiliations

Rutgers, The State University of New Jersey(Current)

Stephen Kamin is an author at Rutgers, The State University of New Jersey specializing in neurology, multiple sclerosis pharmacotherapy, and life sciences.

ORCID

Publications per year

1991–2018

Publications

Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

Raju Kapoor, Pei‐Ran Ho, Nolan Campbell et al. · The Lancet Neurology · 2018 · 337 citations · Full text

Life Sciences, Neurology, Pharmacotherapy +14

Efficacy of treatment of MS with IFNβ-1b or glatiramer acetate by monthly brain MRI in the BECOME study

Diego Cadavid, Leo Wolansky, Joan Skurnick et al. · Neurology · 2009 · 185 citations

Life Sciences, Immunology, Neurology +11

Severe botulism after focal injection of botulinum toxin

Nizar Souayah, Hemmati Karim, Stephen Kamin et al. · Neurology · 2006 · 75 citations

Medicine, Neurology, Neurosurgery +10

Cladribine tablets added to IFN-β in active relapsing MS

Xavier Montalbán, Thomas Leist, Bruce A. Cohen et al. · Neurology Neuroimmunology & Neuroinflammation · 2018 · 63 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +12

Idiopathic myelopathies with white matter vacuolation in non-acquired immunodeficiency syndrome patients

Stephen Kamin, Carol K. Petito · Human Pathology · 1991 · 31 citations · Full text

Life Sciences, Immunology, Pathology +14

1–5 of 6